A detailed history of Bell Investment Advisors, Inc transactions in Insmed Inc stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 27 shares of INSM stock, worth $1,890. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27
Previous 20 35.0%
Holding current value
$1,890
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$62.0 - $79.01 $434 - $553
7 Added 35.0%
27 $1,000
Q4 2023

Feb 14, 2024

BUY
$23.42 - $31.74 $468 - $634
20 New
20 $0
Q2 2022

Aug 12, 2022

SELL
$17.07 - $25.71 $358 - $539
-21 Reduced 53.85%
18 $0
Q4 2021

Feb 14, 2022

SELL
$25.89 - $33.45 $155 - $200
-6 Reduced 13.33%
39 $1,000
Q3 2021

Nov 12, 2021

BUY
$22.46 - $29.47 $1,010 - $1,326
45 New
45 $1,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.48B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Bell Investment Advisors, Inc Portfolio

Follow Bell Investment Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bell Investment Advisors, Inc with notifications on news.